chr3-38761192-G-A
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_006514.4(SCN10A):c.883C>T(p.Pro295Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000244 in 1,601,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 19/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006514.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | c.883C>T | p.Pro295Ser | missense_variant, splice_region_variant | Exon 7 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.883C>T | p.Pro295Ser | missense_variant, splice_region_variant | Exon 6 of 27 | ENSP00000495595.1 | ||||
| SCN10A | ENST00000655275.1 | c.883C>T | p.Arg295Cys | missense_variant | Exon 7 of 28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151706Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000810 AC: 2AN: 246960 AF XY: 0.00000751 show subpopulations
GnomAD4 exome AF: 0.0000262 AC: 38AN: 1449510Hom.: 0 Cov.: 31 AF XY: 0.0000236 AC XY: 17AN XY: 720460 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151706Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74112 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function -
Episodic pain syndrome, familial, 2 Uncertain:1
- -
Brugada syndrome Uncertain:1
This sequence change replaces proline with serine at codon 295 of the SCN10A protein (p.Pro295Ser). The proline residue is weakly conserved and there is a moderate physicochemical difference between proline and serine. This variant also falls at the last nucleotide of exon 6 of the SCN10A coding sequence, which is part of the consensus splice site for this exon. This variant is present in population databases (rs371909817, ExAC 0.002%) but has not been reported in the literature in individuals with a SCN10A-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. In summary, this variant is a rare missense change with uncertain impact on protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at